https://www.indianpharmapost.com/mankind-pharma-q2-fy24-consolidated-pat-higher-at-rs-50102-cr-148442023-11-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/thyrocare-technologies-posts-q2-fy24-consolidated-pat-at-rs-2034-cr-148452023-11-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/ajanta-pharma-posts-q2-fy24-consolidated-pat-at-rs-19530-cr-148462023-11-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/lupin-mandideep-plant-gets-usfda-green-signal-148472023-11-01T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizer-posts-q3-loss-as-covid-19-revenues-shrink-148482023-11-01T00:00:00+05:30always0.9